Valens Co. Inc. (VLNS) News
Filter VLNS News Items
VLNS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VLNS News Highlights
- For VLNS, its 30 day story count is now at 2.
- Over the past 1 day, the trend for VLNS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about VLNS are SNDL and ACT.
Latest VLNS News From Around the Web
Below are the latest news stories about VALENS COMPANY INC that investors may wish to consider to help them evaluate VLNS as an investment opportunity.
THE VALENS COMPANY OBTAINS FINAL COURT ORDER APPROVING THE PROPOSED PLAN OF ARRANGEMENT WITH SNDLThe Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) ("The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to announce today that the Ontario Superior Court of Justice (Commercial List) has granted a final order approving the previously announced plan of arrangement (the "Arrangement") with SNDL Inc. ("SNDL") under Section 192 of the Canada Business Corporations Act in accordance with the terms of the arrangement agreement between Valens and SNDL dated August |
Can you now get a good deal on The Valens Company Inc.’s shares?The share price of The Valens Company Inc. (NASDAQ:VLNS) fell to $0.66 per share on Friday from $0.66. While The Valens Company Inc. has underperformed by -0.39%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VLNS fell by -73.28%, with highs and lows ranging from $3.00 […] |
The Valens Company Granted Additional 180 Calendar Day Grace Period by Nasdaq to Regain Compliance with Minimum Bid Price RuleThe Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced today it received an extension of 180 calendar days from the Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market (the "Bid Price Requirement"), following the expiration of the initial 180 ca |
Valens Shareholders Vote in Favour of the Arrangement with SNDL/PRNewswire/ - The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") is pleased to announce that its shareholders have voted in favour… |
BOTH LEADING INDEPENDENT PROXY ADVISORS RECOMMEND SHAREHOLDERS OF THE VALENS COMPANY INC. VOTE FOR THE PROPOSED ARRANGEMENT WITH SNDL INC.The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" or "Valens") is pleased to announce that both Institutional Shareholder Services ("ISS") and Glass Lewis & Co. ("Glass Lewis") have recommended that Valens shareholders (the "Valens Shareholders") vote in favour of the arrangement resolution at the previously announced Special Meeting of Valens Shareholders (the "Meeting"). The Meeting is being held in connection with the previously announced plan of arrangement (the "Arrangement" |
Valens Secures Sales Licence for Greater Toronto Area Beverage FacilityThe Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, announced it has received a sales licence amendment from Health Canada for its Pommies manufacturing facility located in the Greater Toronto Area (the "GTA Facility") to sell micro processed cannabis products directly to provincial distributors. Prior to this announcement, Valens leveraged its British Columbia sales licence |
THE VALENS COMPANY ANNOUNCES MAILING AND FILING OF CIRCULAR FOR SPECIAL MEETING OF SHAREHOLDERS TO APPROVE ARRANGEMENT WITH SNDL INC.The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (the "Company" or "Valens") is pleased to announce the mailing of its management information circular and related documents for the Special Meeting of Valens Shareholders (the "Meeting") in connection with the previously announced plan of arrangement (the "Arrangement") under section 192 of the Canada Business Corporations Act (the "CBCA") whereby SNDL Inc. ("SNDL") will acquire all of the issued and outstanding common shares of the Company, and |
Valens Shares Slightly Up On Declining Quarterly RevenueThe Valens Company Inc. (TSX:VLNS) (NASDAQ: VLNS ) reported Thursday its third quarter fiscal year 2022 financial results for the period ended August 31, 2022, revealing net revenue of CA$20.3 million ($14.1 million), down by 15.4% from CA$24.0 million in the previous quarter. Quarterly Highlights Despite the decline in net revenue quarter-over-quarter, adjusted gross profit increased by CA$0.9 million in Q3 2022 to CA$5.1 million from CA$4.1 million in Q2 2022. Adjusted EBITDA was a loss of CA$9.8 million, compared to a loss of CA$15.9 million in the previous quarter. Net loss amounted to CA$27.5 million or CA$0.34 per share , versus a loss of CA$160.8 million or $2.13 per … Full story available on Benzinga.com |
The Valens Company Reports Third Quarter Fiscal 2022 Financial ResultsThe Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company", "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, is pleased to report its third quarter fiscal year 2022 financial results for the period ended August 31, 2022. |
The Valens Company to Release Financial Results for the Third Quarter of 2022The Valens Company Inc. (TSX: VLNS) (Nasdaq: VLNS) (the "Company" "The Valens Company" or "Valens") a leading manufacturer of cannabis products, is pleased to announce it will issue its third quarter 2022 financial results for the period ended August 31, 2022, on Thursday, October 13, 2022, before market open. |